Three local health sciences schools are partnering to do research on musculoskeletal disorders in what they described as the first collaborative effort of its kind among the three.
The Kansas City University of Medicine and Biosciences, the University of Missouri-Kansas City and the University of Kansas Medical Center said in a news release Thursday that the goal of the partnership is to focus on diseases of muscle and bone, “thereby accelerating the process of turning discoveries into clinical treatments while also improving research education opportunities for health sciences students.”
The consortium will be led by Lynda Bonewald, vice chancellor for translational and clinical research at UMKC; Jeffrey Joyce, vice president for research at KCU; and Richard Barohn, vice chancellor for research at the KU Medical Center.
“The goal of this consortium is to build powerful research teams of basic to clinical investigators from our three institutions to discover new treatments and cures,” Bonewald said in the release. “These research teams will give our students opportunities to work alongside these researchers to understand and optimally treat musculoskeletal disease.”
Editor’s Note: KCUR is licensed by UMKC.
Dan Margolies, editor of the Heartland Health Monitor team, is based at KCUR.
